Abbott Labs Testosterone Suits Consolidated in Chicago

Abbott Laboratories and AbbVie Inc. will face lawsuits combined in one Chicago court over claims they hid the risks of using the testosterone-replacement drug AndroGel.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.